• No difference in 28-day mortality endpoint between heparin and non-heparin users.
• Lower 28-day mortality in patients with sepsis-induced coagulopathy (SIC) score of ≥4 in stratified analysis
• Odd Ratio (OR) 0.372 (95% CI 0.154–0.901)